Risk assessment of therapeutic agents under consideration to treat COVID‐19 in paediatric patients and pregnant women

Article outlines the considerations for choosing certain agents, dosing and/or adjustments that may be warranted in pregnant women and children in general and specific to the repurposed drugs currently under consideration for treating COVID‐19.

British Journal of Clinical Pharmacology